We are pleased to invite investors and analysts to participate in a live video webcast and conference call on Monday, 11 November 2019, highlighting Roche's early drug development with a focus on pRED.
We would like to invite all interested parties to dial in as outlined below:
14:00 - 15:30 CET / 13:00 - 14:30 GMT
08:00 am - 09:30 am EST / 05:00 am - 06:30 am PST
Live video webcast and conference call will start with presentations by senior management followed by a Q&A session (questions can be asked via phone and webcast).
Agenda
- Welcome
Karl Mahler, Head of Investor Relations
- Overview and introduction to Roche pRED
William Pao, Head of Roche Pharma Research and Early Development
- Oncology
Christian Rommel, Global Head of pRED Oncology
- Neuroscience
Azad Bonni, Global Head of pRED Neuroscience and Rare Diseases
- Ophthalmology
Sascha Fauser, Global Head of pRED Ophthalmology
- Q&A
Access to Video webcast
Please access by clicking on > ir.roche.com
Access to Conference Call (pre-registration required)
You will receive phone numbers, passcode and your personal PIN to direct access the conference call by pre-registering here.
Should you have any issues with the registration, please dial the following numbers on the day of the conference call 10-15 minutes prior to conference start:
+41 (0) 58 310 50 00 (Europe & RoW)
+44 (0) 207 107 0613 (UK)
+1 631 570 56 13 (USA)
A replay of the webcast will be available via > ir.roche.com |
